Acetazolamide and Epilepsy - a phase IV clinical study of FDA data

Summary:

Epilepsy is reported as a side effect among people who take Acetazolamide (acetazolamide), especially for people who are female, 40-49 old, also take Amlodipine, and have Seizures.

The phase IV clinical study analyzes which people have Epilepsy when taking Acetazolamide. It is created by eHealthMe based on reports of 5,933 people who have side effects when taking Acetazolamide from the FDA, and is updated regularly.

What is Acetazolamide?

Acetazolamide has active ingredients of acetazolamide. It is often used in pseudotumor cerebri. eHealthMe is studying from 6,178 Acetazolamide users. Check the latest studies of Acetazolamide.

What is Epilepsy?

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures) is found to be associated with 1,163 drugs and 1,776 conditions by eHealthMe. Check the latest studies of Epilepsy.

On Jul, 08, 2026

5,933 people reported to have side effects when taking Acetazolamide.
Among them, 27 people (0.46%) have Epilepsy.

Among these 27 people:

What is the gender of people who have Epilepsy when taking Acetazolamide? *

female: 80 %
male: 20 %

What is the age of people who have Epilepsy when taking Acetazolamide? *

What are other drugs people take besides Acetazolamide? *

What are other side effects people have besides Epilepsy? *

Drug Ineffective: 15 people, 55.56%
Fever: 9 people, 33.33%
Cough: 7 people, 25.93%
Inflammation: 6 people, 22.22%
High Blood Pressure: 5 people, 18.52%
Vitamin D Decreased: 5 people, 18.52%
Purpura (purplish discoloration of the skin): 5 people, 18.52%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 5 people, 18.52%
Rashes (redness): 5 people, 18.52%
Dyslipidaemia (abnormal amount of lipids): 5 people, 18.52%

What are the existing conditions these people have? *

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 22.22%
Partial Seizures (seizures which affect only a part of the brain at onset): 4 people, 14.81%
Temporal Lobe Epilepsy (a term that refers to a condition where seizures are generated in the portion of the brain called the temporal lobe): 2 people, 7.41%
Psychotic Disorder: 1 person, 3.70%
Osteoporosis (bones weak and more likely to break): 1 person, 3.70%
Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 1 person, 3.70%
Hypotension (abnormally low blood pressure): 1 person, 3.70%
Frontal Lobe Epilepsy (recurring seizures that arise in the frontal lobes of the brain): 1 person, 3.70%
Depression: 1 person, 3.70%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Acetazolamide and have Epilepsy?

- Check whether Epilepsy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Acetazolamide:

Acetazolamide (6,178 reports)

Epilepsy treatments and more:

Epilepsy (129,285 reports)

Browse all side effects of Acetazolamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Epilepsy:

Epilepsy (1,163 drugs)

Browse all the conditions that are associated with Epilepsy:

Epilepsy (1,776 conditions)

Related publications that referenced our studies

Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .
Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .

How the study uses the data?

The study uses data from the FDA. It is based on acetazolamide (the active ingredients of Acetazolamide) and Acetazolamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.